AAAAAA

   
Results: 1-17 |
Results: 17
ASSESSMENT OF BLOOD-PRESSURE IN MILD-TO-MODERATE HYPERTENSIVE PATIENTS FOLLOWING DOUBLE-BLIND CROSSOVER ADMINISTRATION OF AVITRIPTAN, SUMATRIPTAN, OR PLACEBO
Authors: CUTLER NR SALAZAR DE JHEE SS FORD NF FULMOR IE FRANCIS C SRAMEK JJ
Citation: Nr. Cutler et al., ASSESSMENT OF BLOOD-PRESSURE IN MILD-TO-MODERATE HYPERTENSIVE PATIENTS FOLLOWING DOUBLE-BLIND CROSSOVER ADMINISTRATION OF AVITRIPTAN, SUMATRIPTAN, OR PLACEBO, Annals of neurology, 44(3), 1998, pp. 226-226
CLINICALLY SIGNIFICANT CYTOCHROME-P-450 DRUG-INTERACTIONS - A COMMENT
Authors: FORD NF SONNICHSEN DS
Citation: Nf. Ford et Ds. Sonnichsen, CLINICALLY SIGNIFICANT CYTOCHROME-P-450 DRUG-INTERACTIONS - A COMMENT, Pharmacotherapy, 18(4), 1998, pp. 890-891
PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS
Authors: MARINO MR LANGENBACHER KM RAYMOND RH FORD NF LASSETER KC
Citation: Mr. Marino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN PATIENTS WITH HEPATIC CIRRHOSIS, Journal of clinical pharmacology, 38(4), 1998, pp. 347-356
PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN HEALTHY-SUBJECTS
Authors: MARINO MR LANGENBACHER K FORD NF UDERMAN HD
Citation: Mr. Marino et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN IN HEALTHY-SUBJECTS, Journal of clinical pharmacology, 38(3), 1998, pp. 246-255
MONITORING OF ACUTE MIGRAINE ATTACKS - PLACEBO-RESPONSE AND SAFETY DATA
Authors: JHEE SS SALAZAR DE FORD NF FULMOR IE SRAMEK JJ CUTLER NR
Citation: Ss. Jhee et al., MONITORING OF ACUTE MIGRAINE ATTACKS - PLACEBO-RESPONSE AND SAFETY DATA, Headache, 38(1), 1998, pp. 35-38
EFFECTS OF AVITRIPTAN ON BLOOD-PRESSURE IN PATIENTS WITH CONTROLLED MILD-TO-MODERATE HYPERTENSION
Authors: SALAZAR DE JHEE SS SRAMEK JJ FULMOR IE FORD NF CUTLER NR
Citation: De. Salazar et al., EFFECTS OF AVITRIPTAN ON BLOOD-PRESSURE IN PATIENTS WITH CONTROLLED MILD-TO-MODERATE HYPERTENSION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 20-20
BMS-181885 - FIRST HUMAN-EXPERIENCE WITH A POTENT 5-HT1D AGONIST
Authors: FRANC JE WHIGAN DB UDERMAN HD FORD NF SALAZAR DE
Citation: Je. Franc et al., BMS-181885 - FIRST HUMAN-EXPERIENCE WITH A POTENT 5-HT1D AGONIST, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 95-95
PHARMACOKINETICS AND ANTICOAGULANT EFFECT OF BMS-189664 FOLLOWING SINGLE ASCENDING ORAL AND IV DOSES IN HEALTHY MALE-SUBJECTS
Authors: HADJILAMBRIS OW MARINO MR LANGENBACHER KM FORD NF ZIELONKA J CLEMENTI R
Citation: Ow. Hadjilambris et al., PHARMACOKINETICS AND ANTICOAGULANT EFFECT OF BMS-189664 FOLLOWING SINGLE ASCENDING ORAL AND IV DOSES IN HEALTHY MALE-SUBJECTS, Clinical pharmacology and therapeutics, 63(2), 1998, p.
MEASUREMENT OF 2,4-TOLUENEDIAMINE IN URINE AND SERUM SAMPLES FROM WOMEN WITH MEME OR REPLICON BREAST IMPLANTS
Authors: HESTER TR FORD NF GALE PJ HAMMETT JL RAYMOND R TURNBULL D FRANKOS VH COHEN MB
Citation: Tr. Hester et al., MEASUREMENT OF 2,4-TOLUENEDIAMINE IN URINE AND SERUM SAMPLES FROM WOMEN WITH MEME OR REPLICON BREAST IMPLANTS, Plastic and reconstructive surgery, 100(5), 1997, pp. 1291-1298
THE PHARMACOKINETICS OF PRAVASTATIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
Authors: GEHR TWB SICA DA SLUGG PH HAMMETT JL RAYMOND R FORD NF
Citation: Twb. Gehr et al., THE PHARMACOKINETICS OF PRAVASTATIN IN PATIENTS ON CHRONIC-HEMODIALYSIS, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 117-121
THE PHARMACOKINETICS OF IRBESARTAN IN RENAL-FAILURE AND MAINTENANCE HEMODIALYSIS
Authors: SICA DA MARINO MR HAMMETT JL FERREIRA I GEHR TWB FORD NF
Citation: Da. Sica et al., THE PHARMACOKINETICS OF IRBESARTAN IN RENAL-FAILURE AND MAINTENANCE HEMODIALYSIS, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 610-618
EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN
Authors: MARINO MR LANGENBACHER KM FORD NF BEIERLE F SHAMBLEN EC LASSETER KC
Citation: Mr. Marino et al., EFFECT OF HYDROCHLOROTHIAZIDE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 52-52
SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN AFTER SINGLE AND MULTIPLE DOSES IN HEALTHY MALE-SUBJECTS
Authors: MARINO MR LANGENBACHER KM FORD NF UDERMAN HD
Citation: Mr. Marino et al., SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF IRBESARTAN AFTER SINGLE AND MULTIPLE DOSES IN HEALTHY MALE-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 53-53
EVALUATION OF CEREBRAL PHARMACOKINETICS OF THE NOVEL ANTIDEPRESSANT DRUG, BMS-181101, BY POSITRON EMISSION TOMOGRAPHY
Authors: CHRISTIAN BT LIVNI E BABICH JW ALPERT NM DISCHINO DD RUEDIGER E SALAZAR DE FORD NF FISCHMAN AJ
Citation: Bt. Christian et al., EVALUATION OF CEREBRAL PHARMACOKINETICS OF THE NOVEL ANTIDEPRESSANT DRUG, BMS-181101, BY POSITRON EMISSION TOMOGRAPHY, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 325-331
A FIRST-IN-WOMAN STUDY OF A NEW ANTIMIGRAINE DRUG, BMS-180048
Authors: SALAZAR DE FULMOR IE LITKA PA CUTLER NR SMITH RA FORD NF
Citation: De. Salazar et al., A FIRST-IN-WOMAN STUDY OF A NEW ANTIMIGRAINE DRUG, BMS-180048, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 30-30
INVASIVE PHARMACODYNAMICS OF FOSINOPRIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: FORD NF NATARAJAN C FULMOR IE SMITH RA HUI KK
Citation: Nf. Ford et al., INVASIVE PHARMACODYNAMICS OF FOSINOPRIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Journal of clinical pharmacology, 35(8), 1995, pp. 785-793
SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF FOSINOPRIL AND FOSINOPRILAT IN PATIENTS WITH HEPATIC IMPAIRMENT
Authors: FORD NF LASSETER KC VANHARKEN DR HAMMETT JL RAYMOND R MANNING J
Citation: Nf. Ford et al., SINGLE-DOSE AND STEADY-STATE PHARMACOKINETICS OF FOSINOPRIL AND FOSINOPRILAT IN PATIENTS WITH HEPATIC IMPAIRMENT, Journal of clinical pharmacology, 35(2), 1995, pp. 145-150
Risultati: 1-17 |